Bio: Michael Paul

President and CEO of LineaGen, Inc.

Dr. Paul is the President and CEO of LineaGen, Inc., a biotechnology company focused on the discovery and commercialization of biomarker-based molecular diagnostics for the improved diagnosis and treatment of common diseases. Dr. Paul also works closely with vSpring Capital as a Venture Partner in the evaluation of life science investment opportunities. Prior to founding LineaGen, Inc., he was the Chief Operating Officer and President at LineaGen Research Corporation, a Utah non-profit organization from which LineaGen, Inc. was founded. Prior to LineaGen, Dr. Paul worked for Huntsman Biotechnology Corporation as Vice President of Business Development, and for the publicly-traded biopharmaceutical company, NPS Pharmaceuticals as Director of Strategic Development. Dr. Paul has also worked at the University of Utah Technology Transfer Office in the marketing of University inventions to the pharmaceutical and biotechnology industries. Dr. Paul is a licensed patent agent of the United States Patent and Trademark Office and received his B.A. in Biology from Colby College and his Ph.D. in Biochemistry and Molecular Biology from the University of Utah.

| 4/28/2009 9:50:16 AM | 0 Comments